This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: East China University of Science and Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Yuqiong Xu: Innovator in EGFR Inhibition
Introduction
Yuqiong Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Yuqiong Xu holds a patent for the "Use of pteridinone derivative serving as EGFR inhibitor." This invention relates to a pteridinone derivative that acts as an EGFR inhibitor, which is crucial for treating diseases mediated by the epidermal growth factor receptor (EGFR). The patent details a compound represented by a specific formula, along with pharmaceutical compositions that include this compound. The invention aims to provide effective treatments for EGFR-mediated diseases.
Career Highlights
Yuqiong Xu is affiliated with the East China University of Science and Technology, where he engages in research and development activities. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in drug development.
Collaborations
Yuqiong Xu collaborates with notable colleagues, including Honglin Li and Yufang Xu. Their combined expertise enhances the research output and innovation potential within their field.
Conclusion
Yuqiong Xu's work in developing EGFR inhibitors showcases his commitment to advancing medical science. His contributions are vital for the ongoing efforts to create effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile